Psoriasis
Not recruitingStudy on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis
- Disease:Psoriasis
- Substances:Guselkumab
Germany- Participants:18–64 years · 65+ years
- Substances:Guselkumab
- Sponsor:Janssen - Cilag International
Rare diseases
Investigational molecules
Locations
Back to Germany605 clinical trials in Tuebingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on cutaneous lupus erythematosus and psoriatic arthritis, evaluating novel therapeutic approaches for managing chronic inflammatory conditions.
Studies aim to assess new treatment options for improving patient outcomes and quality of life.
Comprehensive studies on various cancer types, including metastatic prostate cancer and basal cell carcinoma, exploring innovative treatment combinations.
Research focuses on improving survival rates and developing more effective treatment strategies.
Groundbreaking research in multiple system atrophy and seizure disorders, investigating new therapeutic approaches for complex neurological conditions.
Clinical trials aim to enhance treatment options for patients with challenging neurological conditions.
Advanced research in eye disorders, including Leber congenital amaurosis and geographic atrophy, focusing on innovative treatment approaches.
Trials aim to preserve and improve vision in patients with rare and progressive eye conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.